Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID‐19

Abstract

Beginning in March 2020, New York City began the fight against coronavirus disease 2019. Health care workers were faced with a disease that led to significant morbidity and mortality with no proven therapies. As hospitals became inundated with patients and underwent rapid expansion of capacity, resources such as drugs, protective and medical equipment, and hospital staff became limited. Pharmacists played a critical role in the management of clinical care and drug delivery during the pandemic. As members of the department of pharmacy within NewYork-Presbyterian Hospital, we describe our experiences and processes to overcome challenges faced during the pandemic. Strict inventory management through the use of daily usage reports, frequent communication, and minimization of waste was critical for the management of drug shortages. The creation of guidelines, protocols, and restrictions were not only used to mitigate drug shortages, but also helped educate health care providers and guided medication use. Managing technology through setting up new automatic dispensing cabinets to address hospital expansions and modifying the electronic order entry system to include new protocols and drug shortage information were also vital. Additional key pharmacist functions included provision of investigational drug service support and training of pharmacists, prescribers, nurses, and respiratory therapists to educate and standardize medication use. Through implementation of operational and clinical processes, pharmacists managed critical drug inventory and guided patient treatment. As the pandemic continues, pharmacists will remain vital members of the multidisciplinary team dedicated to the fight against the virus.

Do wildfires exacerbate COVID-19 infections and deaths in vulnerable communities? Evidence from California

“…Second, focusing on the provision and distribution issues related to hospital and healthcare resources could be another direction that health stakeholders and governments can take to prevent and mitigate the severe consequences of compound emergencies. On the one hand, as advocated by some clinical scholars ( Dzierba et al, 2020 ; Melman et al, 2021 ; Supady et al, 2021 ), hospitals should develop emergency plans for situations in which medical resources and staffing cannot meet urgent needs. For example, how can scarce hospital resources be distributed in a balanced manner, and how can medical resources and scarce intensive care resources be allocated and managed to accommodate patients with different levels of COVID-19 symptoms and different diseases?…”

Medication Use Among Patients With COVID‐19 in a Large, National Dataset: Cerner Real‐World Data™

“…Availability is also a likely determinant of medication use for COVID-19. Several studies describe widespread disruptions in drug manufacturing, difficulties procuring inventory, and drug shortages as important barriers to patient treatment early in the pandemic 37 , 38 . Burry et al note the “highly volatile state of prescribing” that stressed the system and led to quick changes in supply and demand with the release of new (and often conflicting) information 39 .…”

Pharmacy response to COVID-19: lessons learnt from Canada

“…This furthermore encouraged intermittent bolus dosing of neuromuscular blocking agents where possible. If this schedule was not feasible, the lowest dose was targeted in order to achieve ventilator synchrony [ 35 ]. Alternatively, pharmacy staff can be trained to compound specific medications or mix IV medications that are in high demand but undersupplied in order to ensure they are promptly ready on site when needed.…”